News archive

Researchers at the Medical Management Centre (MMC) at the Department of Learning, Informatics, Management and Ethics, presented a new artitcle about policy formulation and implementation at the 8th Annual Conference on the Science of Dissemination and Implementation in Washington DC, USA.

A larger portion of green leafy vegetables in the diet may reduce the risk of developing liver steatosis, or fatty liver. In a study published in PNAS researchers from Karolinska Institutet in Sweden show how a larger intake of inorganic nitrate, which occurs naturally in many types of vegetable, reduces accumulation of fat in the liver. There is currently no approved treatment for the disease, which can deteriorate into life-threatening conditions such as cirrhosis and liver cancer.

Professor Klas Kärre from MTC presented the Nobel Prize in Medicine or Physiology 2018 at the award ceremony in the Concert Hall in Stockholm on the 10th December, 2018.

Doctoral student Anthony Larsson will defend his doctoral thesis on 12 December 2018 at Karolinska Institutet. The thesis covers the fate of biobank initiative BBMRI.se, which was ultimately discontinued by the Swedish Research Council following an investigation. In his thesis, Anthony Larsson describes why the initiative failed. However, his work began on completely different premises.

The study, led by Professor Christina Dalman, will investigate early interventions in mental illness. Christina is group leader of the EPiCSS research group with the Department of Public Health Sciences.

Most researchers will never come close to winning a Nobel Prize. But some are fortunate enough to work with one of the 200 or so living Nobel legends of the research world. In the magazine Medical Science no 4 2018, there is a news article where three KI researchers are interviewed about their collaborations.

Kaj Fried is the recipient of the Swedish Dental Association's International Prize 2018.

There is a large, untapped potential for developing drugs against cancer, fibrosis and cardiovascular diseases by targeting a family of receptors known as Frizzleds, researchers at Karolinska Institutet in Sweden believe. In a new study published in Science Signaling, they identify how these receptors are activated in the cell membrane and the processes that are then triggered within the cell.